title: Continuous glucose monitoring in 2010.
abstract: After the initial positive data several recent randomised controlled trials offer more firm evidence supporting the efficacy and safety of real-time continuous glucose monitoring (CGM) in type 1 diabetes (T1D). Integrating CGM with insulin pumps offers additional benefit. Improved metabolic control with significant lowering of glycated haemoglobin along with other parameters of glycaemia and without a concomitant increase in hypoglycaemia is demonstrated in all age groups, including children and adolescents. Reducing hypoglycaemia with CGM in well-controlled individuals with T1D remains to be demonstrated; however, evidence for reducing hypoglycaemia in critically ill patients seems convincing. Several important aspects of type 2 diabetes (T2D) were recently addressed by professional CGM. Adding predictive algorithms to CGM may considerably improve its efficacy and lead the way towards the closed loop.
authors.affiliation: UMC-University Children's Hospital, Faculty of Medicine, University of Ljubljana, Slovenia. tajed.battelino@mf.uni-lj.si
authors.forename: T
authors.initials: T
authors.lastname: Battelino
authors.forename: B W
authors.initials: BW
authors.lastname: Bode
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood*; D006801:Humans; D018670:Monitoring, Ambulatory / Q000295:instrumentation*
chemical_list: D001786:Blood Glucose